{"schema":"hottub-news/story/v1","story":"st_esbv6x5pnzfbbolefsmq","title":"Semaglutide cuts major heart events, but researchers still cannot fully explain why","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/semaglutide-cuts-major-heart-events-but-researchers-still-cannot-fully-esbv6x5pnz","count":2,"items":[{"id":"n_v5ev5x7he5l5cs7mjhpa","seq":380840,"kind":"article","title":"Le sémaglutide réduit les événements cardiaques majeurs, mais les chercheurs ne peuvent toujours pas expliquer pleinement pourquoi","title_en":"Semaglutide reduces major cardiac events, but researchers still cannot fully explain why","url":"https://ma-clinique.fr/le-semaglutide-reduit-les-evenements-cardiaques-majeurs-mais-les-chercheurs-ne-peuvent-toujours-pas-expliquer-pleinement-pourquoi","summary":"Une analyse détaillée de l’essai SELECT a examiné dans quelle mesure la réduction des événements cardiaques majeurs pouvait être attribuée aux changements de poids, à l’inflammation, à la glycémie et à d’autres facteurs de risque cardiovasculaire. Étude : Semaglutide et réduction du risque cardiovasculaire : une analyse de médiation de l’essai SELECT. Crédit d’image : Édugrafo […] L’article Le sémaglutide réduit les événements cardiaques majeurs, mais les chercheurs ne…","published":"2026-09-28T08:20:21Z","seen":"2026-09-28T08:45:15Z","lang":"fr","source":{"id":"kite-ma-clinique-fr-31ebe5","name":"ma-clinique.fr","domain":"ma-clinique.fr"},"via":"kite-ma-clinique-fr-31ebe5","topics":["medicine","actualités médicales","réduit","chercheurs","peuvent","événements","pleinement","cardiaques"],"authors":["Ma Clinique"],"entities":[{"id":"Q27261089","name":"semaglutide","type":"other"}],"story":"st_esbv6x5pnzfbbolefsmq","category":"health","category_p":0.6000000238418579,"sentiment":"neutral","tone":0.07000000029802322,"political":0.009999999776482582},{"id":"n_esbv6x5pnzfbbolefsmq","seq":337665,"kind":"article","title":"Semaglutide cuts major heart events, but researchers still cannot fully explain why","url":"https://www.news-medical.net/news/20260927/Semaglutide-cuts-major-heart-events-but-researchers-still-cannot-fully-explain-why.aspx","summary":"In adults with overweight or obesity and established cardiovascular disease but no diabetes, semaglutide reduced major adverse cardiovascular events by 20%, while changes in measured cardiovascular risk factors could not fully explain the benefit with certainty. The findings suggest that additional, as-yet unidentified biological pathways may contribute to semaglutide’s cardiovascular protection.","published":"2026-09-28T03:41:00Z","seen":"2026-09-28T04:11:42Z","lang":"en","source":{"id":"kite-news-medical-net-491c44","name":"news-medical.net","domain":"news-medical.net"},"via":"kite-news-medical-net-491c44","topics":["medicine"],"entities":[{"id":"Q27261089","name":"semaglutide","type":"other"}],"image":"https://www.news-medical.net/images/news/ImageForNews_847712_17905667311764008.jpg","mentions":2,"story":"st_esbv6x5pnzfbbolefsmq","category":"health","category_p":0.5400000214576721,"sentiment":"negative","tone":-0.41999998688697815,"political":0.009999999776482582}]}